Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
KT-474/SAR444656 (IRAK4) Phase 2 clinical trials ongoing in HS and AD with data expected in the first half of 2025KT-621 (STAT6)..
The Trial of the Chicago 7
News and Video Search Results
News coverage
-
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
Accesswire
-
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
GlobeNewswire
-
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
-
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
GlobeNewswire
0 shares
1 views
You might like
The Trial of the Chicago 7 media coverage
Current constipation medications don't provide relief for some patients with Chronic Idiopathic Constipation, per Gastroenterologist survey
GlobeNewswire
Vibrant Gastro’s non-pharmaceutical vibrating capsule technology offers alternative for patients to regain control over their..
-
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTYX
GlobeNewswire
-
TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
GlobeNewswire
-
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioVie Inc. of Class Action Lawsuit and Upcoming Deadlines – BIVI
GlobeNewswire
-
Contrast Media Market is Expected to Reach $9.7 Billion | MarketsandMarkets™
GlobeNewswire